Phase II study of Lutetium-177-labeled anti-Carbonic Anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma.
Abstract
Data di Pubblicazione:
2016
Tipologia CRIS:
1.5 Abstract in rivista
Elenco autori:
Muselaers, S; Boers-Sonderen, M; van Oostenbrugge, T; Boerman, O; Desar, I; Stillebroer, A; Mulder, S; van Herpen, C; Langenhuijsen, J; Oosterwijk, E; Oyen, W; Mulders, P
Link alla scheda completa:
Pubblicato in: